Case: A 30-year-old G3P1 with a BMI of 59 and DCDA twins had kell antibody titre of 1:256 at 14+5 wks. Her partner was heterozygous kell positive. Repeat titres were stable through 25 +6 weeks. The MFM unit began consultation at 24 weeks gestation. MFM group consensus was to commence prophylactic IVIG weekly, with fortnightly growth ultrasound and MCA dopplers. She completed 4 IVIG infusions beginning at 26+2 weeks and had 3 serial ultrasounds with normal growth and MCA Dopplers. She presented at 31+5 in preterm labour and underwent an emergency C-section for breech. APGARS were normal. Both twins were DAT positive with maternal anti-K antibodies. Neither twin was anaemic nor had increased bilirubin levels.
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Discussion: Fetal antigen status in this case was not determined. Maternal cell-free DNA testing was not undertaken and there was an increased risk of amniocentesis due to the patients' morbid obesity. The MFM consultant felt the posterior location of the placenta with DCDA twins would result in increased difficulty accessing the umbilical artery for intrauterine transfusion. This concern led to recommendation of prophylactic IVIG transfusions. Previous reports have used IVIG only for patients with second trimester loss due to hydrops or third trimester loss despite fetal transfusion. Background: Wrong blood in tube (WBIT) incidents occur when a patient's blood sample is mislabelled with the details of another patient. Potential consequences of this include severe morbidity and mortality due to transfusion reactions, in addition to the potential for error and result misinterpretation. In obstetrics the potential for severe sudden haemorrhage requiring urgent cross-matching for transfusion is significant, making WBIT a serious issue for our patient group. Following an audit of WBIT incidents in our unit, we designed, delivered and evaluated a specific education package on WBIT targeted at junior medical staff. The education session was delivered by an existing resident working in our hospital (first author CM).
PREVENTING WRONG BLOOD IN TUBE ERRORS IN OBSTETRICS: A PEER-LED EDUCATION PACKAGE
Methods: A video education package focussing on environmental and personal factors associated with an increased risk of sample labelling errors, and outlining good practice strategies was delivered to 33 incoming residents attending a hospital orientation session. The residents were surveyed regarding their prior knowledge of WBIT and their response to the education package.
Results: 12% of the residents surveyed had never previously heard of WBIT. 100% of the residents had received no previous education on this issue. 94% of the residents stated that they found the peer-led education initiative helpful.
Conclusions: Peer-led education on WBIT and its potential consequences was felt to be a useful initiative. We plan to reaudit the incidence of WBIT in our hospital in the 6 months following the education package, to see if there has been a positive impact on the rate of WBIT errors. Background: Non-invasive prenatal testing (NIPT) refers to a maternal blood test used to screen for chromosomal abnormalities, performed as early as 10 weeks gestation, which has recently become available in Australia. NIPT is currently only available privately with no Medicare rebate.
NON-INVASIVE PRENATAL TESTING: KNOWLEDGE AND OPINIONS OF ANTENATAL HEALTHCARE PROVIDERS AND PATIENTS
Objectives: • To evaluate awareness and uptake of NIPT among pregnant women and antenatal care providers (ANCPs).
• To identify ethical concerns of ANCPs surrounding the current and future uses of NIPT. Methods: Women who were currently pregnant or had given birth in the previous 2 months (the patient group) self-selected to complete an anonymous survey in the waiting rooms of private obstetricians.
ANCPs were invited to complete an anonymous survey which was mailed to their workplace.
Results: Of the patient group surveyed, 82% had heard of NIPT and 100% said they would consider undergoing NIPT in certain circumstances. NIPT would mainly be used by this group in the instance of a high risk pregnancy. The ANCP group had a 38% response rate. Various ethical concerns regarding NIPT's potential uses and the informed consent and referral process were raised.
Conclusions: The patient group had a strong awareness of NIPT and a desire to be offered the choice to undergo NIPT. ANCP's opinions regarding NIPT highlighted the potential benefit of the development of guidelines surrounding streamlining the use of NIPT in practice. Mechanical ventilation of preterm neonates can cause brain inflammation and injury, and increase the risk of adverse neurological outcomes such as cerebral palsy. We aimed to determine if giving human amnion epithelial cells (hAECs) to ventilated preterm lambs would affect measures of neurological inflammation and cell development in the brain white and grey matter.
THE EFFECT OF HUMAN AMNION EPITHELIAL CELLS IN BRAINS OF VENTILATED PRETERM LAMBS
Methods: Preterm lambs were born by caesarean section (after antenatal corticosteroid exposure) at 128-130 days' gestation (term is~147 days) and ventilated for 48 hours. Lambs received 3 mL surfactant (Curosurf) via endotracheal
